Related references
Note: Only part of the references are listed.Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis
Yanqiong Liu et al.
BMC MEDICINE (2014)
Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer
S. Zanutto et al.
BRITISH JOURNAL OF CANCER (2014)
MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer
Nicolai A. Schultz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Serum miR-21 is a diagnostic and prognostic marker of primary central nervous system lymphoma
Xuhua Mao et al.
NEUROLOGICAL SCIENCES (2014)
Diagnostic and Prognostic Implications of a Serum miRNA Panel in Oesophageal Squamous Cell Carcinoma
Caiyun Wu et al.
PLOS ONE (2014)
Serum MicroRNA-21 as a Diagnostic Marker for Lung Carcinoma: A Systematic Review and Meta-Analysis
Xiaorong Yang et al.
PLOS ONE (2014)
Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer
Paola Mozzoni et al.
BIOMARKERS (2013)
Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer
A. Shiotani et al.
BRITISH JOURNAL OF CANCER (2013)
Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma
Xiong Liu et al.
CANCER BIOLOGY & THERAPY (2013)
Plasma miR-21 is a novel diagnostic biomarker for biliary tract cancer
Tomoya Kishimoto et al.
CANCER SCIENCE (2013)
Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia
Amal A. Abd-El-Fattah et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2013)
Serum circulating microRNA profiling for identification of potential breast cancer biomarkers
Fermin Mar-Aguilar et al.
DISEASE MARKERS (2013)
Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer
Dongfang Tang et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2013)
MicroRNA-21: a therapeutic target for reversing drug resistance in cancer
Liu Hong et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
The advantage of circulating tumor cells over serum carcinoembryonic antigen for predicting treatment responses in rectal cancer
Wenjie Sun et al.
FUTURE ONCOLOGY (2013)
CA19.9 antigen circulating in the serum of colon cancer patients: Where is it from?
Lydia Mare et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Serum miR-21 as a Diagnostic and Prognostic Biomarker in Colorectal Cancer
Yuji Toiyama et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma
Liu Ouyang et al.
MEDICAL ONCOLOGY (2013)
Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection
Enders K. O. Ng et al.
PLOS ONE (2013)
Identification and Evaluation of Plasma MicroRNAs for Early Detection of Colorectal Cancer
Xiaoya Luo et al.
PLOS ONE (2013)
Potential Role of microRNA-21 in the Diagnosis of Gastric Cancer: A Meta-Analysis
Zongyue Zeng et al.
PLOS ONE (2013)
Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer
Guang-Hui Liu et al.
TUMOR BIOLOGY (2013)
Plasma MiR-21 A Potential Diagnostic Marker of Colorectal Cancer
Ziad Kanaan et al.
ANNALS OF SURGERY (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis
Xi Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors
Bing Wang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma
Qiong Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma
Yoshito Tomimaru et al.
JOURNAL OF HEPATOLOGY (2012)
Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients
Han-Bo Le et al.
MEDICAL ONCOLOGY (2012)
Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study
Angela M. Liu et al.
BMJ OPEN (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer
Sota Asaga et al.
CLINICAL CHEMISTRY (2011)
miR-1254 and miR-574-5p Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer
Kristen M. Foss et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Plasma microRNAs as potential biomarkers for non-small-cell lung cancer
Jun Shen et al.
LABORATORY INVESTIGATION (2011)
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in Patients With Hepatocellular Carcinoma or Chronic Hepatitis
Jian Xu et al.
MOLECULAR CARCINOGENESIS (2011)
Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer
Fulya Yaman Agaoglu et al.
TUMOR BIOLOGY (2011)
Multivariate random effects meta-analysis of diagnostic tests with multiple thresholds
Taye H. Hamza et al.
BMC MEDICAL RESEARCH METHODOLOGY (2009)
MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease
Jin Wang et al.
CANCER PREVENTION RESEARCH (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
I. A. Asangani et al.
ONCOGENE (2008)
Micrornas: Small RNAs with a big role in gene regulation
L He et al.
NATURE REVIEWS GENETICS (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Share Paper
